Eisai’s Small Molecule Analog Reduced Inflammation and Injury in Mice with IBD, Study Shows

Eisai’s Small Molecule Analog Reduced Inflammation and Injury in Mice with IBD, Study Shows
A small molecule analog developed by Eisai, called ER-464195-01,  may be a potential therapy for patients with inflammatory bowel disease (IBD) by reducing infiltration of inflammatory cells, according to researchers. Their study, “Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel disease,” was published in the journal Nature Communications. IBD is a group of diseases that are characterized by repeated inflammation in the lining of the large or small intestines. One
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *